History of uses, phytochemistry, pharmacological activities, quality control and toxicity of the root of Stephania tetrandra S. Moore: A review
| Autor: | Yuelin Zhang, Yukun Zhang, Yanquan Gao, Huan Qin, Chun-Xia Liang, Zhe Ma, Zhidong Liu, Xunan Song, Hui Peng, Yiting Liu, Xinru Sun, Yingpeng Li, Ying Zhang, Dongli Qi |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Quality Control
Fangchinoline Phytochemistry Astringent Traditional Chinese medicine Plant Roots Stephania tetrandra 03 medical and health sciences 0302 clinical medicine Antimicrobial effect Drug Discovery Animals Humans Medicine Chinese pharmacopoeia Medicine Chinese Traditional 030304 developmental biology Pharmacology 0303 health sciences biology Traditional medicine Plant Extracts business.industry biology.organism_classification 030220 oncology & carcinogenesis Toxicity business Drugs Chinese Herbal |
| Zdroj: | Journal of Ethnopharmacology. 260:112995 |
| ISSN: | 0378-8741 |
| DOI: | 10.1016/j.jep.2020.112995 |
| Popis: | Ethnopharmacological relevance the root of Stephania tetrandra S. Moore, known as Fangji in China (Chinese: 防己), is a traditional Chinese medicine (TCM) with a long history of use. Fangji is a type of medicine used to treat various diseases, including rheumatism, arthralgia, edema and beriberi, unfavorable urination, and eczema. Aim of this review There are many newly published reports on the history of uses, phytochemistry, pharmacological activity, quality control and toxicity of Fangji; however, no comprehensive systematic review exists. Therefore, the purpose of this review is to compile the latest and most comprehensive information on Fangji and provide a scientific basis for future research. Materials and methods A systematic literature search was conducted using multiple electronic databases, including SciFinder, Web of Science, PubMed, Science Direct, ACS Publications, J-stage, SpringerLink, Thieme, Wiley, and CNKI. Information was also collected from journals and Chinese Pharmacopoeia. Result Thus far, there were uses of Fangji against 20 different diseases/disorders, such as relieving edema and rheumatism pain, treating cough and asthma, treating enuresis, astringent urine and beriberi edema, purging blood and damp heat, and dispelling wind evil and dampness, etc. 48 compounds have been isolated from Fangji, belonging to alkaloids, flavonoids, and steroids, other compounds. The crude extracts and isolated compound of Fangji have shown a wide range of pharmacological activities, such as anti-tumor, anti-inflammatory, and neuroprotective activities, as well as role in reoxygenation, and antimicrobial effect, etc. Moreover, qualitative and quantitative analyses of quality control are reviewed, including qualitative analyses for the identification of compounds, as well as fingerprint and quantitative analyses by high performance liquid chromatography (HPLC) and capillary electrochromatography (CE). In the toxicity study, the hepatotoxicity, hepatorenal toxicity, nephrotoxicity, subacute and acute toxicities of the alcohol extract and water extract of Fangji, and tetrandrine were studied in-vitro and in-vivo experiments. Conclusion In the history of uses, Fangji can be used to treat a variety of diseases, most of which are manifested in removing wind and dampness. In recent years, the phytochemistry of Fangji has rarely been reported. The pharmacological activities of Fangji mainly focus on the compounds, tetrandrine and fangchinoline, and there are a few reports on the pharmacological studies of other compounds in Fangji. Moreover, the quality control of Fangji lacks a standard fingerprint to distinguish Fangji from other easily-confused medicinal materials. In the toxicity study, there is no report on the mechanism of toxicity research. Therefore, further studies on such mechanisms are needed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect